Guidelines recommend breastfeeding in cystic fibrosis (CF) but breastfeeding rates decline rapidly in CF. We initiated a quality improvement project to improve breastfeeding in CF by incorporating International Board-Certified Lactation Consultants (IBCLC) into the initial CF-diagnosis visit to support mothers who were breastfeeding at diagnosis. In the preintervention group, only 8/14 (57%) continued to provide breast milk after the first visit, whereas postintervention, 16/17 (94%) mothers continued to do so (P = 0.03). The duration of any (or partial) breastfeeding increased to an average of 7.7 months from an average of 6.4 months preintervention (P = 0.45). The weight z score and weight-for-length z score at diagnosis showed no change at 6 or 12 months (all comparisons P value >0.05). We conclude that mothers who met with the IBCLC were less likely to quit breastfeeding and hypothesize that lactation support to mothers can prolong the duration of breastfeeding in infants with CF.
*Clinical Nutrition, Children's Hospital of Wisconsin
†Section of Pediatric Pulmonary and Sleep Medicine, Medical College of Wisconsin
‡Cystic Fibrosis Center
§SE Wisconsin SAMPRO™
||Lactation Management Services, Children's Hospital of Wisconsin
¶Pediatric Gastroenterology and Nutrition, Medical College of Wisconsin, WI.
Address correspondence and reprint requests to Praveen S. Goday, MBBS, CNSC, Professor, Pediatric Gastroenterology and Nutrition, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226 (e-mail: email@example.com).
Received 11 December, 2018
Accepted 13 May, 2019
P.S.G. serves as consultant to Nutricia and serves on a Data Safety and Monitoring Board for Shire Pharmaceuticals. The remaining authors have no financial relationships relevant to this article to disclose.